MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.pan.2024.05.515

Медицинская библиотека · Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2024

Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication.

Singh Isha, Chou Joanne F, Capanu Marinela, Park Jennifer, Yu Kenneth H, Varghese Anna M, Park Wungki, Zervoudakis Alice, Keane Fergus, Rolston Vineet Syan, Gerdes Hans, Wei Alice C, Shah Pari, Covey Anne, Schattner Mark, O'Reilly Eileen M

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Acute cholangitis (AC) is a common complication of pancreatic ductal adenocarcinoma (PDAC). Herein, we evaluated outcomes after the first AC episode and predictors of mortality and AC recurrence in patients with stage IV PDAC.

METHODS

We conducted a single-center, retrospective observational study using institutional databases. Clinical data and outcomes for patients with stage IV PDAC and at least one documented episode of AC, were assessed. Overall survival (OS) was estimated using the Kaplan-Meier method, and Cox regression model was employed to identify predictors of AC recurrence and mortality.

RESULTS

One hundred and twenty-four patients with stage IV PDAC and AC identified between January 01, 2014 and October 31, 2020 were included. Median OS after first episode of AC was 4.1 months (95 % CI, 4.0-5.5), and 30-day, 6, and 12-month survival was 86.2 % (95 % CI, 80.3-92.5), 37 % (95 % CI, 29.3-46.6 %) and 18.9 % (95 % CI, 13.1-27.3 %), respectively. Primary tumor in pancreatic body/tail (HR 2.29, 95 % CI: 1.26 to 4.18, p = 0.011), concomitant metastases to liver and other sites (HR 1.96, 95 % CI: 1.16 to 3.31, p = 0.003) and grade 3 AC (HR 2.26, 95 % CI: 1.45 to 3.52, p < 0.001), predicted worse outcomes. Intensive care unit admission, sepsis, systemic therapy, treatment regimen, and time to intervention did not predict survival or risk of recurrence of AC.

CONCLUSIONS

AC confers significant morbidity and mortality in advanced PDAC. Worse outcomes are associated with higher grade AC, primary tumor location in pancreatic body/tail, and metastases to liver and other sites.

Для цитирования: Singh Isha, Chou Joanne F, Capanu Marinela, Park Jennifer, Yu Kenneth H, Varghese Anna M, Park Wungki, Zervoudakis Alice, Keane Fergus, Rolston Vineet Syan, Gerdes Hans, Wei Alice C, Shah Pari, Covey Anne, Schattner Mark, O'Reilly Eileen M. Morbidity and mortality in patients with stage IV pancreatic adenocarcinoma and acute cholangitis: Outcomes and risk prognostication.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2024. DOI: 10.1016/j.pan.2024.05.515.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.